Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases

Ocular drug delivery is challenging due to the presence of anatomical and physiological barriers. These barriers can affect drug entry into the eye following multiple routes of administration (e.g., topical, systemic, and injectable). Topical administration in the form of eye drops is preferred for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachu, Rinda Devi, Chowdhury, Pallabitha, Al-Saedi, Zahraa H. F., Karla, Pradeep K., Boddu, Sai H. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874841/
https://www.ncbi.nlm.nih.gov/pubmed/29495528
http://dx.doi.org/10.3390/pharmaceutics10010028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874841/
https://www.ncbi.nlm.nih.gov/pubmed/29495528
http://dx.doi.org/10.3390/pharmaceutics10010028

Ejemplares similares